We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine×マーケットリサーチセンター - List of Manufacturers, Suppliers, Companies and Products

medicine Product List

61～75 item / All 465 items

Displayed results
[Research Material] The Global Market for the Treatment of Psoriasis

[Research Material] The Global Market for the Treatment of Psoriasis

World Market for Psoriasis Treatment: Topical Therapy, Phototherapy, Systemic Drugs, Biological Therapy, Hospitals, Clinics, Others

This research report (Global Plaque Psoriasis Treatment Market) investigates and analyzes the current state and outlook for the global market for the treatment of psoriasis over the next five years. It includes information on the overview of the global psoriasis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the psoriasis treatment market focus on topical therapies, phototherapy, systemic drugs, and biological therapies, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size for psoriasis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in psoriasis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ovarian Cancer Treatment Drugs

[Research Material] Global Market for Ovarian Cancer Treatment Drugs

Global Market for Ovarian Cancer Treatments: PARP, PD-L1, Angiogenesis Inhibitors, Hospitals, Research

This research report (Global Ovarian Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for ovarian cancer therapeutics over the next five years. It includes information on the overview of the global ovarian cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on PARP, PD-L1, and angiogenesis inhibitors, while the segments by application target hospitals and research. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for ovarian cancer therapeutics. It also includes the market share of major companies in the ovarian cancer therapeutics sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Small Interfering RNA (siRNA) Therapeutics

[Research Material] Global Market for Small Interfering RNA (siRNA) Therapeutics

Global Market for Low Molecular Weight Interfering RNA (siRNA) Therapeutics: Liposome-based Systemic Therapy, Nanoparticle-based Systemic Therapy, Others, Hospitals, Research Institutions ...

This research report (Global Small Interfering RNA (siRNA) Therapeutics) investigates and analyzes the current status and future outlook of the global market for small interfering RNA (siRNA) therapeutics over the next five years. It includes information on the global overview of the small interfering RNA (siRNA) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for small interfering RNA (siRNA) therapeutics by type include liposome-based systemic therapy, nanoparticle-based systemic therapy, and others, while the segments by application target hospitals, research institutions, pharmaceutical and biotechnology companies, academic institutions, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for small interfering RNA (siRNA) therapeutics. The report also includes information on the market share of major companies in the small interfering RNA (siRNA) therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Intestinal Bacterial Infections

[Research Material] Global Market for Treatments of Intestinal Bacterial Infections

World Market for Treatments of Intestinal Bacterial Infections: Beta-lactam Drugs, Carbapenem Drugs, Fluoroquinolone Drugs, Others, Hospital Pharmacies, Retail Pharmacies ...

This research report (Global Enterobacteriaceae Infection Drug Market) investigates and analyzes the current status and outlook for the global market of drugs for treating Enterobacteriaceae infections over the next five years. It includes information on the overview of the global Enterobacteriaceae infection drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-lactam drugs, carbapenem drugs, fluoroquinolone drugs, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Enterobacteriaceae infection drugs. It also includes the market share of major companies in the Enterobacteriaceae infection drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Lymphoblastic Leukemia Treatment Drugs

[Research Material] Global Market for Acute Lymphoblastic Leukemia Treatment Drugs

World Market for Acute Lymphoblastic Leukemia Treatment Drugs: Chemotherapy, Targeted Therapy, Radiation Therapy, Stem Cell Transplantation, Hospitals, Pharmacies

This research report (Global Acute Lymphoblastic Leukemia Therapeutics M) investigates and analyzes the current state and outlook for the global market of acute lymphoblastic leukemia therapeutics over the next five years. It includes information on the overview of the global acute lymphoblastic leukemia therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include chemotherapy, targeted therapy, radiation therapy, and stem cell transplantation, while the segments by application focus on hospitals and pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acute lymphoblastic leukemia therapeutics. It also includes the market share of major companies in the acute lymphoblastic leukemia therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Dermatophyte Nail Fungal Infection (DOT)

[Research Material] Global Market for Treatment of Dermatophyte Nail Fungal Infection (DOT)

Global Market for Treatment of Dermatophyte Nail Fungal Infections (DOT): Systemic Therapy, Topical Therapy, Others, Hospitals, Dermatology Clinics, Others

This research report (Global Dermatophytic Onychomycosis Treatment Market) investigates and analyzes the current state and future outlook of the global market for dermatophytic onychomycosis treatment (DOT) over the next five years. It includes information on the overview of the global dermatophytic onychomycosis treatment (DOT) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for dermatophytic onychomycosis treatment (DOT) by type include systemic therapy, topical therapy, and others, while the segments by application focus on hospitals, dermatology clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for dermatophytic onychomycosis treatment (DOT). It also includes the market share of major companies in dermatophytic onychomycosis treatment (DOT), product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【Research Material】Global Market for Glomerulonephritis Treatment

【Research Material】Global Market for Glomerulonephritis Treatment

Global Market for Glomerulonephritis Treatment: ACH-5228, AMY-101, Atacicept, Abacopan, AVX-002, Home Healthcare, Clinics, Hospitals

This research report (Global Glomerulonephritis Treatment Market) investigates and analyzes the current status and outlook for the global glomerulonephritis treatment market over the next five years. It includes information on the overview of the global glomerulonephritis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the glomerulonephritis treatment market focus on ACH-5228, AMY-101, Atacicept, Abatacept, and AVX-002, while the segments by application target home healthcare, clinics, and hospitals. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for glomerulonephritis treatment. It also includes the market share of major companies in glomerulonephritis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Cachexia Treatment

[Research Material] The Global Market for Cachexia Treatment

World Market for Cachexia Treatment: Weight Stabilizers, Appetite Stimulants, Progestogens, Corticosteroids, Combination Therapy, Others, Hospital Pharmacies, Retail Pharmacies, ...

This research report (Global Cachexia Treatment Market) investigates and analyzes the current state and future outlook of the global cachexia treatment market over the next five years. It includes information on the overview of the global cachexia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cachexia treatment market include weight stabilizers, appetite stimulants, progestogens, corticosteroids, combination therapies, and others, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and online. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cachexia treatment. It also includes the market share of major companies in cachexia treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Tumor Treatment Drugs

[Research Material] Global Market for Tumor Treatment Drugs

Global Market for Tumor Treatment Drugs: Chemotherapy, Targeted Therapy, Immunotherapy (Biological Therapy), Hormonal Therapy, Others, Hematological Cancers, Breast Cancer, Gastrointestinal Cancers, ...

This research report (Global Oncology Drugs Market) investigates and analyzes the current status and outlook for the global market of oncology drugs over the next five years. It includes information on the overview of the global oncology drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oncology drugs market include chemotherapy, targeted therapy, immunotherapy (biological therapy), hormone therapy, and others, while the segments by application cover hematologic cancers, breast cancer, gastrointestinal cancers, prostate cancer, respiratory cancers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of oncology drugs. It also includes the market share of major companies in oncology drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Non-Hodgkin Lymphoma Treatment Drugs

[Research Material] Global Market for Non-Hodgkin Lymphoma Treatment Drugs

World Market for Non-Hodgkin Lymphoma Treatment Drugs: Chemotherapy, Targeted Therapy, Clinical Research, Treatment

This research report (Global Non-Hodgkin Lymphoma Therapeutics Market) investigates and analyzes the current status and outlook for the global market of non-Hodgkin lymphoma therapeutics over the next five years. It includes information on the overview of the global non-Hodgkin lymphoma therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on chemotherapy and targeted therapy, while the segments by application target clinical research and treatment. The regional segments calculate the market size of non-Hodgkin lymphoma therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in non-Hodgkin lymphoma therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment Drugs for Dilated Cardiomyopathy

[Research Material] Global Market for Treatment Drugs for Dilated Cardiomyopathy

Global Market for Treatment of Dilated Cardiomyopathy: Aldosterone Antagonists, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor ...

This research report (Global Dilated Cardiomyopathy Therapeutic Market) investigates and analyzes the current state and future outlook of the global market for dilated cardiomyopathy therapeutics over the next five years. It includes information on the overview of the global dilated cardiomyopathy therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include aldosterone antagonists, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and beta-blockers, while the segments by application focus on hospitals and academic institutions. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for dilated cardiomyopathy therapeutics. The report also includes the market share of major companies in the dilated cardiomyopathy therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Smoking Cessation Medications

[Research Material] Global Market for Smoking Cessation Medications

Global Market for Smoking Cessation Medications: NRT Products, Nicotine-Free Products, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Smoking Cessation Drugs Market) investigates and analyzes the current state of the global market for smoking cessation drugs and its outlook for the next five years. It includes information on the overview of the global smoking cessation drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the smoking cessation drug market focus on NRT products and nicotine-free products, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for smoking cessation drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the smoking cessation drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Factor VIII Deficiency

[Research Material] The Global Market for Treatment of Factor VIII Deficiency

World Market for Treatment of Factor VIII Deficiency: Hemophilia A Drugs, Hemophilia A Inhibitor Treatment, von Willebrand Disease Treatment, Hospitals, Clinics, Others

This research report (Global Factor VIII Deficiency Treatment Market) investigates and analyzes the current status and outlook for the global market for Factor VIII deficiency treatment over the next five years. It includes information on the overview of the global Factor VIII deficiency treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Factor VIII deficiency treatment market focus on hemophilia A drugs, hemophilia A inhibitor treatments, and von Willebrand disease treatments, while the segments by application target hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for Factor VIII deficiency treatment. It also includes the market share of major companies in Factor VIII deficiency treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Dermatological Treatments

[Research Material] The Global Market for Dermatological Treatments

World Market for Dermatological Treatments: Antimicrobials, Corticosteroids, Antipsoriatics, Anti-acne, Others, Hospitals, Clinics

This research report (Global Dermatological Remedies Market) investigates and analyzes the current status and outlook for the global dermatological treatment market over the next five years. It includes information on the overview of the global dermatological treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the dermatological treatment market include anti-infectives, corticosteroids, anti-psoriasis, anti-acne, and others, while the segments by application focus on hospitals and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for dermatological treatments. It also includes the market share of major companies in dermatological treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Myelodysplastic Syndromes (MDS)

[Research Material] The Global Market for Treatment of Myelodysplastic Syndromes (MDS)

World Market for Myelodysplastic Syndromes (MDS) Treatment: Azacitidine, Lenalidomide, Decitabine, Deferasirox, Monoclonal Dysplasia...

This research report (Global Myelodysplastic Syndrome (MDS) Treatment Market) investigates and analyzes the current status and outlook for the global market for myelodysplastic syndrome (MDS) treatment over the next five years. It includes information on the overview of the global myelodysplastic syndrome (MDS) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the myelodysplastic syndrome (MDS) treatment market by type include azacitidine, lenalidomide, decitabine, and deferasirox, while the segments by application focus on refractory cytopenia with unilineage dysplasia, refractory anemia with ringed sideroblasts, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for myelodysplastic syndrome (MDS) treatment. It also includes the market share of major companies in the myelodysplastic syndrome (MDS) treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.